Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2004
09/02/2004WO2004073709A1 Antimicrobial agents
09/02/2004WO2004073642A2 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
09/02/2004WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004WO2004073601A2 Process for the preparation of hexacyclic camptothecin derivatives
09/02/2004WO2004035569A3 Novel compounds with antibacterial activity
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide
09/02/2004US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
09/02/2004US20040171630 both receptor-type and non-receptor type tyrosine kinases; to treat angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases,
09/02/2004US20040171618 Compounds as PDE IV and TNF-inhibitors
09/02/2004US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004US20040171075 Modulation of protein functionalities
09/02/2004DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles
09/02/2004CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004CA2516590A1 Substituted n-aryl nitrogen heterocycles
09/02/2004CA2515706A1 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands
09/02/2004CA2508731A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1451175A1 Thrombin inhibitors
09/01/2004EP1451167A1 Phenylalkynes
09/01/2004EP1450808A1 Quinazoline derivatives for the treatment of t cell mediated diseases
09/01/2004EP1292594B1 Quinazoline derivatives for the treatment of tumours
09/01/2004EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
09/01/2004EP0893423B1 Liquid crystal compounds having fluorinated linkages, liquid crystal compositions, and liquid crystal display devices
09/01/2004EP0880502B1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
09/01/2004CN1525961A Method for the production of 1-amino-3-phenyl- uracil derivatives
09/01/2004CN1525960A Lorenz Gisela
09/01/2004CN1525959A Muller Klaus-helmut
09/01/2004CN1164577C Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
08/2004
08/31/2004US6784293 Solution and solid-phase synthesis of boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/ dihydrothiouracils
08/31/2004US6784171 Reaction of methyl 2-amino-4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5-carboxylate with methanesulfonyl chloride in the presence of strong base, reaction of the intermediate with a methylating agent in presence of strong base
08/31/2004US6783946 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
08/26/2004WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors
08/26/2004WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
08/26/2004WO2004072066A1 Tri(cyclo) substituted amide glucokinase activator compounds
08/26/2004WO2004072049A1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
08/26/2004WO2004072048A1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004WO2004045500A3 Process for synthesizing antifolates
08/26/2004WO2004018461A3 Antibacterial benzoic acid derivatives
08/26/2004US20040167358 Method and reagents for N-alkylating ureides
08/26/2004US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
08/26/2004US20040167198 Vasculostatic agents and methods of use thereof
08/26/2004US20040167143 High speed metabolism; antiepileptic agents; anesthetics; central nervous system disorders; anxiolytic agents
08/26/2004US20040167142 Pyrimidinone compounds
08/26/2004US20040167140 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
08/26/2004US20040167135 Dihydropyrimidines
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167120 Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
08/26/2004US20040167116 Viricides
08/26/2004DE10305785A1 New 2-(2-phenylpiperanyl-3-phenyl-dihydroquinazolinyl)-acetic acid derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections
08/25/2004EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
08/25/2004EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/25/2004EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
08/25/2004EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade
08/25/2004EP1448533A1 Dithiocarbamate derivatives and their use as antibacterial agents
08/25/2004EP1448532A1 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
08/25/2004EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
08/25/2004EP1159271B1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
08/25/2004EP1087963B1 Inhibitors of glycogen synthase kinase 3
08/25/2004CN1524079A Novel sulfamides and their use as endothelin receptor antagonists
08/25/2004CN1523018A Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same
08/25/2004CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy
08/24/2004US6780992 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
08/24/2004US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2
08/24/2004US6780869 Selective inhibitor of cox-2; antiinflammatory agent
08/24/2004US6780821 Substituted phenyl uracils
08/19/2004WO2004069847A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells
08/19/2004WO2004069846A1 Pyrimidines, methods for the production thereof, and use thereof
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004069812A1 Pyrimidine derivatives for the prevention of hiv infection
08/19/2004WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004WO2004069794A2 New arylpiperazinyl compounds
08/19/2004WO2004069791A2 Preparation of substituted quinazolines
08/19/2004WO2004069145A2 Anticancer compounds, process for their preparation and pharmaceutical compositions containing them
08/19/2004WO2004069139A2 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity
08/19/2004WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
08/19/2004WO2004048335A3 Mandelic acid derivatives
08/19/2004WO2004009036A3 Compounds compositions and methods
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162430 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162303 4-aminopyrimidine-5-one derivatives
08/19/2004US20040162302 Novel crystal of arylethenesulfonamide derivative and preparation process thereof
08/19/2004US20040162300 As inhibitor of tyrosine kinase enzymes, therapy of cancer
08/19/2004US20040162299 Substituted quinazolines and analogs and the use thereof
08/19/2004US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/19/2004US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors
08/19/2004CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004CA2514933A1 Preparation of substituted quinazolines
08/19/2004CA2513915A1 New arylpiperazinyl compounds
08/19/2004CA2512915A1 4-aminopyrimidine-5-one
08/18/2004EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
08/18/2004EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
08/18/2004EP1446402A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
08/18/2004EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists
08/18/2004EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
08/18/2004EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors
08/18/2004EP1294366B1 Pharmaceutical compounds for treating copd